Potential Significance of Targeting Ferroptosis for Intervention of Diabetic Cardiomyopathy
Journal of Diabetes · 2025
DOI: 10.1111/1753-0407.70116 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Qian Lei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesia and Operation Center, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and T…. Hauptthemen laut MEDLINE: Ferroptosis, Diabetic Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Provincial Science and Technology Program, Clinical Research Program of the National Health Commission of China.
Abstract (Originalsprache)
Background
Diabetes represents a significant global health concern, with diabetic cardiomyopathy (DCM) emerging as a primary cause of mortality among individuals with diabetes. Despite the prevalence of DCM, advancements in therapeutic and preventative strategies remain constrained.
Methods
Recent studies were reviewed to provide a comprehensive summary of pathogenesis and clinical treatment of DCM, effect of ferroptosis, and potential value of ferroptosis inhibitors in DCM intervention.
Results
A growing body of research indicates that oxidative stress, inflammatory reactions, and other factors play a role in the onset and progression of DCM. Oxidative stress within cardiomyocytes is a primary mechanism implicated in the development of DCM, whereby heightened intracellular reactive oxygen species (ROS) facilitate cell death via ferroptosis. Ferroptosis inhibitors hold great promise as therapeutic agents.
Conclusions
This review provides an overview of the involvement of iron homeostasis regulation, oxidative stress, and ferroptosis in DCM, and the significance of ferroptosis in the prevention and treatment of DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anesthesia and Operation Center, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Sunnybrook Research Institute, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
- Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Juanjuan Lyu
Förderung
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Program
- Clinical Research Program of the National Health Commission of China
- the Fundamental Research Funds for the Central Universities
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Lei, Q., Yang, B. B., & Lyu, J. (2025). Potential Significance of Targeting Ferroptosis for Intervention of Diabetic Cardiomyopathy. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70116
Vancouver
Lei Q, Yang BB, Lyu J. Potential Significance of Targeting Ferroptosis for Intervention of Diabetic Cardiomyopathy. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70116
BibTeX
@article{Lei2025,
author = {Lei, Qian and Yang, Burton B and Lyu, Juanjuan},
title = {Potential Significance of Targeting Ferroptosis for Intervention of Diabetic Cardiomyopathy},
journal = {Journal of Diabetes},
year = {2025},
doi = {10.1111/1753-0407.70116}
}
EUVIMED